Alzheimer's Disease Trial, By Invitation
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults over 18 years old who are willing to give a blood sample.
- People who have completed a full clinical and psychological assessment.
- Brain imaging scans may also be used if available, though this is not required as it is not suitable for everyone.
- People without a muscle disease or neurological disease diagnosis may be eligible to join as a comparison group (control), matched by age and sex to patients in the study.
- Control participants are usually spouses or children of patients who have been told about the study at a participating clinic.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People for whom neuropsychological test data is not available.
- People who are currently taking blood-thinning medications such as acenocoumarol, heparin, warfarin, dabigatran, rivaroxaban, or apixaban.
- People who have used recreational drugs or abused substances in the past year.
- People with a history of cancer affecting the brain or spinal cord that has not been in full remission for at least five years.
- People who have previously received certain chemotherapy drugs that may be harmful to the nervous system, or who have had radiation treatment to the head.
- People with a clinical diagnosis of Alzheimer's disease where biological markers found in spinal fluid or blood do not match what would be expected in Alzheimer's disease (confirm with trial site).
- Cognitively healthy volunteers whose biological markers found in spinal fluid or blood do show signs consistent with Alzheimer's disease or another brain-related condition.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Concentration of biomarkers in blood; Diagnosis; Boston Naming Test
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.